Behavioral analysis can provide a lot of information about the health status or motivations of a living being.
Alnylam abandons plans for RNAi drug Onpattro after FDA hits the brakes – Pharmaceutical Technology
The CRL is a complete turnaround from the positive recommendation Onpattro received in September from an FDA Advisory Committee (AdCom) panel regarding the label expansion.